Abstract:Abstract RNA N6-methyladenosine (m6A) modification occurs in approximately 25% of mRNAs at the transcriptome-wide level. RNA m6A is regulated by the RNA m6A methyltransferases methyltransferase-like 3 (METTL3), METTL14, and METTL16 (writers), demethylases FTO and ALKBH5 (erasers), and binding proteins YTHDC1–2, YTHDF1–3, IGF2BP1–3, and SND1 (readers). These RNA m6A modification proteins are frequently upregulated or downregulated in human cancer tissues and are often associated with poor patient prognosis. By modulating pre-mRNA splicing, mRNA nuclear export, decay, stability, and translation of oncogenic and tumor suppressive transcripts, RNA m6A modification proteins regulate cancer cell proliferation, survival, migration, invasion, tumor initiation, progression, metastasis, and sensitivity to anticancer therapies. Importantly, small-molecule activators of METTL3, as well as inhibitors of METTL3, FTO, ALKBH5, and IGF2BP1 have recently been identified and have shown considerable anticancer effects when administered alone or in combination with other anticancer agents, both in vitro and in mouse models of human cancers. Future compound screening and design of more potent and selective RNA m6A modification protein inhibitors and activators are expected to provide novel anticancer agents, appropriate for clinical trials in patients with cancer tissues harboring aberrant RNA m6A modification protein expression or RNA m6A modification protein–induced resistance to cancer therapy.

The Potential Roles of RNA N6-Methyladenosine in Urological Tumors

The emerging roles of N6-methyladenosine RNA methylation in human cancers

The potential role of RNA N6-methyladenosine in Cancer progression

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

Function of N6-Methyladenosine Modification in Tumors

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

The Roles of M6a RNA Modifiers in Human Cancer

Current researches on N6-methyladenosine and its functions in solid tumors

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

The role of m6A RNA methylation in human cancer

RNA N 6 -methyladenosine modifications in urological cancers: from mechanism to application

Roles and Implications of Mrna N6 -Methyladenosine in Cancer.

RNA M6a Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications.

The N6-Methyladenosine Modification and Its Role in Mrna Metabolism and Gastrointestinal Tract Disease

Functions of N6-methyladenosine and Its Role in Cancer

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy

The Emerging Roles of RNA m6A Methylation and Demethylation as Critical Regulators of Tumorigenesis, Drug Sensitivity, and Resistance

The Roles of N6-methyladenosine and Its Target Regulatory Noncoding RNAs in Tumors: Classification, Mechanisms, and Potential Therapeutic Implications.

N6-Methyladenosine: A Novel RNA Imprint in Human Cancer

Mechanisms of N6‑methyladenosine Modification in Tumor Development and Potential Therapeutic Strategies (Review)

Mechanism of RNA Modification N6-methyladenosine in Human Cancer.